Genetic and antigenic characterization of a serotype P[6]G9 human rotavirus strain isolated in the United States

Virology

Volumn 256, Issue 1, 1999, Pages 45-53

  Kirkwood, Carl D ^a   Gentsch, Jon R ^a   Hoshino, Yasutaka ^b   Clark, H Fred ^c   Glass, Roger I ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; HYPERIMMUNE GLOBULIN; MONOCLONAL ANTIBODY; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN ROTAVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; UNITED STATES; VIRUS INFECTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS TYPING;

EID: 0033616522     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9591     Document Type: Article

References (42)

1. Bernstein D. I., Glass R. I., Rodgers G., Davidson B. L., Sack D. A. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. J. Am. Med. Assoc. 273:1995;1191-1196.
2. Chen D. Y., Estes M. K., Ramig R. F. Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope. J. Virol. 66:1992;432-439.
3. Clark H. F., Hoshino Y., Bell L. M., Groff J., Hess G., Bachman P., Offit P. A. Rotavirus isolate W161 representing a presumptive new human serotype. J. Clin. Microbiol. 25:1987;1757-1762.
4. Coulson B. S., Fowler K. J., Bishop R. F., Cotton R. G. H. Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. J. Virol. 54:1985;14-20.
5. Cunliffe N. A., Gondwe J. S., Graham S. M., Broadhead R. L., Molyneux M. E., Woods P. A., Bresee J. S., Glass R. I., Gentsch J. R., Hart C. A. Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: Predominance of novel P[6]98 strains. J. Med. Virol. 57:1999.
6. Cunliffe N. A., Woods P. A., Ward R. L., Leite J. P. G., Das B. K., Ramachandran M., Bhan M. K., Hart C. A., Glass R. I., Gentsch J. R. Sequence analysis of NSP4 gene of human rotavirus allows classification into two main genetic groups. J. Med. Virol. 53:1997;41-50.
7. Das B. K., Gentsch J. R., Hoshino Y., Ishida S.-I., Nakagomi O., Bhan M. K., Kumar R., Glass R. I. Characterization of the G serotype and genogroup of New Delhi newborn rotavirus strain 116E. Virology. 197:1993;99-107.
8. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:1984;387-395.
9. Dunn S. J., Burns J. W., Cross T. L., Vo P. T., Ward R. L., Bremont M., Greenberg H. B. Comparison of VP4 and VP7 of five murine rotavirus strains. Virology. 203:1994;250-259.
10. Estes M. Rotaviruses and their replication. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 1625-1655.
11. Estes M. K., Cohen J. Rotavirus gene structure and function. Microbiol. Rev. 53:1989;410-449.
12. Felsenstein J. PHYLIP - Phylogeny inference package (version 3.2). Cladistics. 5:1989;164-166.
13. Gentsch J. R., Glass R. I., Woods P., Gouvea V., Gorziglia M., Flores J., Das B. K., Bhan M. K. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 30:1992;1365-1373.
14. Gentsch J. R., Woods P. A., Ramachandran M., Das B. K., Leite J. P., Alfieri A., Kumar R., Bhan M. K., Glass R. I. Review of G and P typing results from a global collection of strains: Implications for vaccine development. J. Infect. Dis. 174:1996;S30-36.
15. Gorziglia M., Green K., Nishikawa K., Taniguchi K., Jones R., Kapikian A. Z., Chanock R. M. Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J. Virol. 62:1988;2978-2984.
16. Gouvea V., Glass R. I., Woods P., Taniguichi K., Clark H. F., Forrester B., Fang Z. Y. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J. Clin. Microbiol. 28:1990;276-282.
17. Green K. Y., Hoshino Y., Ikegami N. Sequence analysis of the gene encoding the serotype-specific glycoprotein (VP7) of two new human rotavirus serotypes. Virology. 168:1989;429-433.
18. Hoshino Y., Wyatt R. G., Greenberg H. B. Serotypic similarity and diversity of rotaviruses of mammalian and avian origins as studies by plaque reduction neutralization. J. Infect. Dis. 149:1984;694-702.
19. Kapikian A. Z., Chanock R. M. Rotaviruses. Fields B. N., Knipe D. M., Howley P. M., Chanock R. M., Melnick J. L., Monath T. P., Roizman B., Straus S. E. Fields Virology. 1996;1657-1708 Lippincott-Raven, Philadelphia.
20. Kirkwood C. D., Palombo E. A. Genetic characterization of the rotavirus nonstructural protein, NSP4. Virology. 236:1997;258-265.
21. Kirkwood C., Masendycz P. J., Coulson B. S. Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotaviruses. Virology. 196:1993;79-88.
22. Kirkwood C. D., Bishop R. F., Coulson B. S. Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites. Arch. Virol. 141:1996;587-600.
23. Kobayashi N., Taniguchi K., Urasawa S. Identification of operationally overlapping and independent cross-reactive neutralization regions on human rotavirus VP4. J. Gen. Virol. 71:1990;2615-2623.
24. Nakagomi O., Nakagomi T., Akatani K., Ikegami N. Identification of rotavirus genogroups by RNA-RNA hybridization. Mol. Cell. Probes. 3:1989;251-261.
25. Nakagomi O., Nakagomi T., Akatani K., Ikegami N., Katsushima N. Relative frequency of rotavirus serotypes in Yamagata, Japan, over four consecutive rotavirus seasons. Res. Virol. 141:1990;459-463.
26. Nakagomi T., Akatani K., Ikegami N., Katsushima N., Nakagomi O. Occurrence of changes in human rotavirus serotypes with concurrent changes in genomic RNA electropherotypes. J. Clin. Microbiol. 26:1988;2586-2592.
27. Padilla-Noriega L., Werner-Eckert R., Mackow E. R., Gorziglia M., Larralde G., Taniguchi K., Greenberg H. B. Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J. Clin. Microbiol. 31:1993;622-628.
28. Padilla-Noriega L., Dunn S. J., Lopez S., Greenberg H. B., Arias C. F. Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5 and VP8 of human rotavirus ST3. Virology. 206:1995;148-154.
29. Palombo E. A., Bishop R. F. Genetic and antigenic characterization of a serotype G6 human rotavirus isolated in Melbourne, Australia. J. Med. Virol. 47:1995;348-354.
30. Palombo E. A., Bishop R. F. Sequences of VP6 genes of human rotavirus strain RV3 and its vaccine derivative. J. Gen. Virol. 75:1994;2415-2419.
31. Ramachandran M., Das B. K., Vij A., Kumar R., Bhambal S. S., Kesari N., Rawat H., Bahl L., Thakur S., Woods P. A., Glass R. I., Bhan M. K., Gentsch J. R. Unusual diversity of human rotavirus G and P genotypes in India. J. Clin. Microbiol. 34:1996;436-439.
32. Ramachandran M., Gentsch J. R., Parashar U. D., Jin S., Woods P. A., Holmes J. L., Kirkwood C. D., Bishop R. F., Greenberg H. B., Urasawa S., Gerna G., Coulson B. S., Taniguchi K., Bresee J. S., Glass R. I. Detection and characterization of novel rotavirus strains in the United States. J. Clin. Microbiol. 36:1998;3223-3229.
33. Rennels M. B., Glass R. I., Dennehy P. H., Bernstein D. I., Pichichero M. E., Zito E. T. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines: Report of the national multicenter trial. Pediatrics. 97:1996;7-13.
34. Santos N. V., Ripenhoff-Talty M., Clark H. F., Offit P., Gouvea V. VP4 genotyping of human rotavirus in the United States. J. Clin. Microbiol. 32:1994a;205-208.
35. Santos N. V., Gouvea V., Timenetsky M. C., Clark H. F., Riepenholf-Talty M., Garbarg-Chenon A. Comparative analysis of the VP8* sequences from rotaviruses possessing M37-like VP4 recovered from children with and without diarrhoea. J. Gen. Virol. 75:1994b;1775-1780.
36. Taniguchi K., Hoshino Y., Nishikawa K., Green K. Y., Maloy W. L., Morita Y., Urasawa S., Kapikian A. Z., Chanock R. M., Gorziglia M. Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: Nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J. Virol. 62:1988a;1870-1874.
37. Taniguchi K., Maloy W. I., Nishikawa K., Green K. Y., Hoshino Y., Urasawa S., Kapikian A. Z., Chanock R. M., Gorziglia M. Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J. Virol. 62:1988b;2421-2426.
38. Timenetsky M. do C., Santos N., Gouvea V. Survey of rotavirus G and P types associated with human gastroenteritis in Sao Paulo, Brazil, from 1986 to 1992. J. Clin. Microbiol. 32:1994;2622-2624.
39. Timenetsky M. do C., Gouvea V., Santos N., Carmona R. C., Hoshino Y. A novel human rotavirus serotype with dual G5-G11 specificity. J. Gen. Virol. 78:1997;1373-1378.
40. Tucker A. W., Haddix A. C., Bresee J. S., Holman R. C., Parashar U. D., Glass R. I. Cost-effectiveness analysis of a rotavirus immunization program for the United States. J. Am. Med. Assoc. 279:1998;1371-1376.
41. Urasawa S., Hasegawa A., Urasawa T., Taniguchi K., Wakasugi F., Suzuki H., Inouye S., Pongprot B., Supawadee J., Suprasert S., Rangsiyanond P., Tonusin S., Yamazi Y. Antigenic and genetic analyses of human rotaviruses in Chiang Mai, Thailand: Evidence for a close relationship between human and animal rotaviruses. J. Infect. Dis. 166:1992;227-234.
42. Wyatt R. G., Greenberg H. B., James W. D. Definition of human rotavirus serotypes by plaque reduction assay. Infect. Immun. 37:1984;110-115.